|
LPP expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.306200E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.471610E-01 |
| Normal-vs-Stage2 |
4.922400E-02 |
| Normal-vs-Stage3 |
3.695500E-02 |
| Normal-vs-Stage4 |
3.121300E-03 |
| Stage1-vs-Stage2 |
2.671400E-01 |
| Stage1-vs-Stage3 |
2.784200E-01 |
| Stage1-vs-Stage4 |
3.646300E-02 |
| Stage2-vs-Stage3 |
7.795000E-01 |
| Stage2-vs-Stage4 |
5.582000E-01 |
| Stage3-vs-Stage4 |
3.033000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.673800E-02 |
| Normal-vs-AfricanAmerican |
4.39580000000106E-05 |
| Normal-vs-Asian |
8.074800E-01 |
| Caucasian-vs-AfricanAmerican |
2.787400E-04 |
| Caucasian-vs-Asian |
3.404000E-01 |
| AfricanAmerican-vs-Asian |
1.880490E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.341500E-02 |
| Normal-vs-Female |
3.172400E-02 |
| Male-vs-Female |
9.107800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.512000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.654600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.177800E-03 |
| Normal-vs-Age(81-100Yrs) |
2.512200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.805200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.749600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.734400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.290340E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.146100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.450600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.249000E-01 |
| Normal-vs-Grade 2 |
1.905830E-01 |
| Normal-vs-Grade 3 |
9.403700E-03 |
| Normal-vs-Grade 4 |
3.343500E-03 |
| Grade 1-vs-Grade 2 |
2.545200E-01 |
| Grade 1-vs-Grade 3 |
5.352200E-02 |
| Grade 1-vs-Grade 4 |
2.037500E-02 |
| Grade 2-vs-Grade 3 |
1.303160E-01 |
| Grade 2-vs-Grade 4 |
2.482000E-02 |
| Grade 3-vs-Grade 4 |
2.604200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.991000E-01 |
| Normal-vs-ccB subtype |
1.846000E-01 |
| ccA subtype-vs-ccB subtype |
6.501000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.184100E-02 |
| Normal-vs-N1 |
4.727600E-01 |
| N0-vs-N1 |
8.576400E-01 |
|
|
